Clin2
NCT07516899Possibly a fitNot yet recruiting

How Your Body Processes a New Experimental Drug

Huntington Disease

Part of Brain & nervous system, Genetic & congenital, Mental health clinical trials.

This study tests how a healthy male body absorbs, uses, and removes a new experimental medication. Researchers track the drug's path through your body using a special radioactive marker to understand how it works and ensure it's safe.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
8 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • You are a healthy adult male, between 18 and 45 years old
  • Your weight and body composition fall within a normal range (BMI 19–26 kg/m², weight at least 50 kg)
  • You have no plans to father children or donate sperm for at least 1 year and agree to use strict contraception
  • You stop taking all medications, supplements, and herbal products for at least 4 weeks before the study
  • You are willing to stay in the research facility for testing and follow a standard diet throughout the trial
  • You have no serious heart conditions, digestive problems, or history of drug abuse

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06634628Recruiting· Early Phase 1
Testing a new brain scan tracer for Huntington's disease

This trial tests a new radioactive tracer called [11C]CHDI-00491009 that may show mutant huntingtin protein in the brain using a PET scan. It aims to find out if the tracer is safe and helps see Huntington's disease changes. If you have early-stage Huntington's or are a healthy volunteer, you may be able to join.

Leuven
NCT06576401Recruiting· Phase 1
HDM1002 metabolism study in healthy Chinese men

This study tests how a new drug called HDM1002 leaves the body, using a tiny amount of a radioactive marker. It's for healthy men, and the results will help researchers understand how the drug works.

Suzhou, Jiangsu
NCT07656779Not yet recruiting· Phase 1
How HRS-1893 moves through the body in healthy men

This study looks at how a single dose of an investigational drug called HRS-1893 is processed and removed from the body in healthy men. You'll stay at the clinic and provide blood and urine samples for several days.

Wuxi, Jiangsu
NCT07681479Not yet recruiting· Phase 1
How a drug tracer moves through healthy men

This study uses a tiny amount of radioactive tracer in an injection to see how the drug moves through the body and leaves it. It is only for healthy men between 18 and 45.

Nanjing, Jiangsu
NCT06701110Recruiting· Phase 1
Study of sudapyridine in healthy Chinese men

This trial tests how Sudapyridine (WX-081) moves through the body in healthy Chinese men. It helps researchers understand the drug's effects and safety before moving to later studies.

Suzhou, Jiangsu
NCT06584058Not yet recruiting
HPP737 study in healthy Chinese men

This study tests how the body processes the experimental drug HPP737 in healthy Chinese men. It helps researchers understand how the drug is absorbed, broken down, and eliminated.

Suzhou, Jiangsu

Hear when a new Huntington Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.